HEAD & NECK CANCERS

Latest News

Perioperative Pembrolizumab Betters Survival in Stage III/IV Head and Neck Cancer
Perioperative Pembrolizumab Betters Survival in Stage III/IV Head and Neck Cancer

October 8th 2024

The KEYNOTE-689 study evaluating pembrolizumab in this patient population met its primary end point of event-free survival.

Experts Reach Consensus on Detecting Extranodal Extension in HNC Imaging
Experts Reach Consensus on Detecting Extranodal Extension in HNC Imaging

October 2nd 2024

Camrelizumab Boosts EFS in Nasopharyngeal Carcinomas
Camrelizumab Boosts EFS in Nasopharyngeal Carcinomas

September 27th 2024

Neoadjuvant Therapy Could Improve Outcomes for Nasal and Paranasal Sinus Cancer
Neoadjuvant Therapy Could Improve Outcomes for Nasal and Paranasal Sinus Cancer

September 17th 2024

Improving Imaging Guidelines for Extranodal Extension in Head and Neck Cancer
Improving Imaging Guidelines for Extranodal Extension in Head and Neck Cancer

August 24th 2024